Plancorp Cut By $319,166 Its Abbott Labs (ABT) Stake; Nuveen Preferred & Income Term Fund (JPI) Sentiment Is 0.95

January 19, 2018 - By Clifton Ray

Nuveen Preferred and Income Term Fund is a close ended balanced mutual fund launched by Nuveen Investments, Inc. The company has market cap of $. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It currently has negative earnings. It invests into public equity and fixed income markets across the globe.

Plancorp Llc decreased Abbott Labs (ABT) stake by 23.93% reported in 2017Q3 SEC filing. Plancorp Llc sold 6,022 shares as Abbott Labs (ABT)’s stock declined 3.42%. The Plancorp Llc holds 19,141 shares with $1.02M value, down from 25,163 last quarter. Abbott Labs now has $102.82 billion valuation. The stock increased 0.14% or $0.08 during the last trading session, reaching $59.07. About 5.66 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since January 19, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

Investors sentiment decreased to 0.87 in Q3 2017. Its down 0.01, from 0.88 in 2017Q2. It is negative, as 47 investors sold ABT shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported. American Century Incorporated reported 2.01 million shares. Tortoise Inv Lc invested in 356 shares or 0.01% of the stock. Forte Cap Limited Liability Corporation Adv holds 0.11% or 6,163 shares in its portfolio. Voya Inv Mngmt Ltd Liability Company accumulated 0.1% or 834,352 shares. Kopp Investment Advsr Lc has 3,827 shares for 0.19% of their portfolio. The North Carolina-based Bragg Fincl Inc has invested 0.55% in Abbott Laboratories (NYSE:ABT). 22,894 were reported by Thomas White. Halsey Associates Incorporated Ct reported 26,868 shares. Rampart Invest Mngmt Ltd, a Massachusetts-based fund reported 23,368 shares. Jones Lllp invested in 157,323 shares. Cypress Asset Mngmt Tx accumulated 46,863 shares or 0.54% of the stock. Bollard Grp Ltd Liability Corp owns 118,544 shares or 0.33% of their US portfolio. Capital City Fl holds 6,712 shares. 34,410 were reported by Hedeker Wealth Ltd Liability. Deroy And Devereaux Private Invest Counsel Inc accumulated 4,612 shares.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 92 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Abbott Laboratories (NYSE:ABT) has “Equal-Weight” rating given on Tuesday, July 11 by Morgan Stanley. Barclays Capital upgraded the stock to “Overweight” rating in Wednesday, October 7 report. The rating was maintained by RBC Capital Markets on Thursday, October 19 with “Buy”. On Tuesday, August 15 the stock rating was maintained by Cowen & Co with “Buy”. The rating was maintained by Gabelli on Friday, July 21 with “Buy”. The rating was downgraded by Piper Jaffray on Thursday, April 28 to “Neutral”. BTIG Research maintained the shares of ABT in report on Saturday, August 29 with “Buy” rating. As per Friday, January 29, the company rating was maintained by RBC Capital Markets. The company was maintained on Saturday, August 29 by Deutsche Bank. The company was maintained on Tuesday, March 15 by Jefferies.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on January, 24 before the open. They expect $0.73 EPS, up 12.31% or $0.08 from last year’s $0.65 per share. ABT’s profit will be $1.27B for 20.23 P/E if the $0.73 EPS becomes a reality. After $0.66 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 10.61% EPS growth.

Since August 1, 2017, it had 0 insider purchases, and 6 insider sales for $22.86 million activity. The insider Fussell Stephen R sold 196,550 shares worth $9.73M. Shares for $3.31 million were sold by Salvadori Daniel Gesua Sive on Tuesday, September 26. Contreras Jaime sold $2.74 million worth of stock or 52,700 shares. 2,000 Abbott Laboratories (NYSE:ABT) shares with value of $98,323 were sold by Bracken Sharon J.

Icm Asset Management Inc Wa holds 3.35% of its portfolio in Nuveen Preferred and Income Term Fund for 114,505 shares. Robinson Capital Management Llc owns 92,531 shares or 1.04% of their US portfolio. Moreover, Jacobus Wealth Management Inc. has 1.02% invested in the company for 154,714 shares. The California-based National Planning Corp has invested 0.54% in the stock. E&G Advisors Lp, a Texas-based fund reported 25,000 shares.